key: cord-1038119-ojhqqgeu authors: Konozy, Emadeldin H.E.; Osman, Makarim E.M.; Iesa, Mohamed A.M. title: SARS-CoV-2 and Plasmodium falciparum are probably adopting Analogous strategy to invade erythrocytes date: 2021-06-09 journal: J Infect Public Health DOI: 10.1016/j.jiph.2021.04.014 sha: d850464f3adf2283dfe657e50507e55fdb8e679c doc_id: 1038119 cord_uid: ojhqqgeu nan . The proportion of confirmed cases of malaria in 2018 in Africa (according to WHO countries profile reports from health facilities) and the proportion of accumulative confirmed cases of COVID-19 reported on Nov 3, 2020 (WHO situation report). tected, the same ABO blood group system's susceptibility was found to apply to COVID-19 patients [13, 14] , at severe stages, both are associated with coagulopathy [15, 16] , and lastly the sharing of certain immunodominant regions between the two microbes [17] . Though antimalarial drugs like chloroquine, hydroxychloroquine, and artemisinin are used by some countries' health authorities for the treatment of COVID-19; chloroquine and hydroxychloroquine have been removed a few years ago from the malaria protocol due to detected Plasmodium resistance to the drugs [18] . Many West African countries adopted chloroquine for many years as one of the most common drugs for the treatment of malaria, among which Uganda, Burkina Faso, Mali and Guinea-Bissau. Interestingly, these countries remained to report the least number of COVID-19 incidences (Fig. 1) . The malaria data presented in this figure were attained from WHO 2018 malaria country report. To discuss malaria endemicity and COVID-19 in Africa in a more comprehensive way, It would have been ideal to incorporate malaria data for 2019, however, unfortunately, these data have not been made publicly available. The mechanism implicated in SARS-COV2-host cell infection is mediated through interactions of the virus surface spike (S) glycoprotein with the angiotensin-COnverting enzyme-2 (ACE2) receptor, a receptor that expressed widely in most of the human organ's cells [19] but lacked in mature erythrocytes [20] . CD147 a member of the human immunoglobulin superfamily which is also termed basigin, a transmembrane glycoprotein receptor is expressed in the erythrocytes. This receptor is noted to mediate the blood stage of P. falciparum infection, blockage of this receptor by a humanized antibody inhibits the parasite infection [21] . Under in vivo conditions, a nano-lipid formulation Metadichol ® was found to inhibit the host cell-SARS-CoV-2 interactions and consequently the virus entry [22] . Concurrently and strikingly, the same chemical could successfully inhibit the P. falciparum logically by obstructing the CD147 receptor [23] . Though the fact of the use of the CD147 (basigin) receptor by SARS-CoV2 as an alternative entry route remained controversial, some in-vitro proofs have recently arisen in support of this allegation. Wang and his colleagues have proven distinct strong interactions between CD147 and SARS-CoV2 spike glycoproteins, these interactions were obstructed by using Meplazumab a humanized anti-CD147 immunoglobulin-2 antibody which consequently resulted in viral replication inhibition. Moreover, using the CD147 knockout stable cells Vero E6, led to a sharp decline of the viral load. These developments bolstered the authors' suggestion of the possibility of the existence of an alternative SARS-CoV-2 infection route via CD147 [24] . A Chinese controversial in-silico study demonstrated that the viral non-structural proteins Orf3a and Orf1ab assist in viral haemoglobin attacks, by dissociating the iron from heme [25] . Major of the criticism faced by these authors was based on the fact that erythrocytes do not possess replication machinery (no nucleus) that would sustain the virus's life cycle. However, other suggestion in support of the Liu and Li hypothesis is already proclaimed, in which the attack of SARS-CoV-2 to the marrow's immature erythrocytes (contain a nucleus) is hypothesized [26] . This data has been recently substantiated by investigating COVID-19 patients' RBCs in which deformed erythrocytes with sickled shape and vacuolization of the cytoplasm that customarily induced by viruses attack were spotted [27] . Furthermore, a very recent study put forward by an English research group has proven a direct infection of erythroid progenitors by SARS-CoV-2 at severe stages of the disease [28] . The rosette formation phenomenon is a situation associated with severe cases of malaria in which P. falciparum-infected RBCs become stickier and subsequently facilitate the adherence of the healthier ones to them, which would culminate in clots formation [29] . Also, Coagulopathy or thrombosis in COVID-19 acute cases is well documented, and high morbidity rates were attributed, on several occasions, to clot formation that would finally lead to thromboembolism and death [30, 31] . These manifestations are usually accompanied by elevated laboratory markers such as D-dimer, fibrinogen, and low lymphocyte numbers [32] [33] [34] . A similar outcome is also noticeable in some malaria patients [35, 36] . In our research group's recent findings, we have demonstrated possible shared targets for immune response between SARS-CoV-2 and P. falciparum by immunoinformatic approach. P. falciparum-thrombospondin related adhesive protein (PfTRAP), a protein family that aids with the erythrocyte invasion by the parasite is found to share five immunodominant regions located at three SARS-CoV-2 proteins (i.e., nucleocapsid, Orf1ab, and Orf3a proteins) [17] . Malaria is often a disease of children from the first few months of life to the age of about 5 years, becoming less common in older children and adults as specific acquired immunity gives increasing (although always incomplete) protection [37] . This acquired immunity might likely reduce the susceptibility to possible SARS-CoV-2 infection. Moreover, SARS-CoV-2 detection in peripheral blood specimens occurs merely in hospitalized patients and severe cases, with a detection rate between 9 to 40% [38] . Hence it is unlikely that all Africans who are susceptible to malaria be also for COVID-19. The common pathological manifestations of COVID-19 and malaria in terms of (1) the blood group susceptibility, (2) the coagulopathy associated with severe stages of the two diseases, (3) the elevation or decrease of certain serum biomarkers, (4) the shared immunodominant epitopes regions between SARS-CoV-2 and P. falciparum and lastly (5) the low incidence rate of COVID-19 in the malaria-endemic zones, all together may permit us to hypothesize a conceivable role for the erythrocytes in COVID-19 pathogenicity. The erythrocyte's SARS-CoV-2 invasion is presumably taking place through RBC's CD147 receptor. Furthermore, these striking pathological and immunological resemblances between SARS-CoV-2 and P. falciparum may likely pave the way in the chase for efficient vaccine manufacturing for both diseases. No funding sources. None declared. Not required. COVID-19: unpacking the low number of cases in Africa Africa's low COVID-19 mortality rate: a paradox? WHO coronavirus disease (COVID-19) DashboardNov The effect of climate on the spread of the COVID-19 pandemic: a review of findings, and statistical and modelling techniques COVID-19 pandemic -an African perspective Plasmodium falciparum infection may protect a population from severe acute respiratory syndrome coronavirus 2 infection Coronavirus disease 2019 (COVID 19) and Malaria: have anti glycoprotein antibodies a role? Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19 Effects of weather on coronavirus pandemic Is hydroxychloroquine beneficial for COVID-19 patients? Antimalarial drugs inhibit the replication of SARS-CoV-2: an in vitro evaluation Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis Individuals with a Rh-positive but not Rh-negative blood group are more vulnerable to SARS-CoV-2 infection: demographics and trend study on COVID-19 cases in Sudan Dysregulation of coagulation in cerebral malaria COVID-19 coagulopathy: an indepth analysis of the coagulation system SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data The pivotal link between ACE2 deficiency and SARS-CoV-2 infection RRM prediction of erythrocyte Band3 proteinas alternative receptor for SARS-CoV-2 virus Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum Metadichol ® , a novel nano lipid formulation that inhibits SARS-CoV-2 and a multitude of pathological viruses in vitro CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review Erythrocytes as a target of SARS CoV-2 in pathogenesis of COVID-19 Human erythroid progenitors are directly infected by SARS-CoV-2: implications for emerging erythropoiesis in severe COVID-19 patients Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria Sudden death due to acute pulmonary embolism in a young woman with COVID-19 Thrombosis and COVID-19 pneumonia: the clot thickens! Vasculopathy and coagulopathy associated with SARS-CoV-2 infection Cerebral venous thrombosis associated with COVID-19 SARS-CoV-2 and coagulation disorders in different organs Persistently elevated laboratory markers of thrombosis and fibrinolysis after clinical recovery in malaria points to residual and smouldering cellular damage Blood coagulation, inflammation, and malaria WHO severe malaria Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens